An interventional study of Audio signal processing (applied offline before playback) in Hearing Loss, sponsored by Phonak AG, Switzerland. Completed at 1 site in Switzerland. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2015-10-20.
Sponsored by Phonak AG, Switzerland · Not applicable, Interventional, and Treatment
Hearing impaired persons suffer from inferior music perception with and without hearing aids. Hearing aids, however, are primarily designed to improve speech intelligibility not music enjoyment. This study investigates the potential benefit of signal processing strategies that are optimized for music. The purpose of this study is to improve music compression for hearing impaired people.
1,109 studies on the registry are indexed under Hearing Loss; 233 are open to participants now.
This study's enrollment of 20 is below the median of 40 across 778 interventional studies indexed under Hearing Loss.
Browse Hearing Loss studies →Phonak AG, Switzerland is the lead sponsor of 7 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants compare music signals with preprocessing to the same music signals without compressive preprocessing.
Other: Audio signal processing (applied offline before playback)
Benefit of signal processing for music perception
Participants rate the enjoyment of music in 4 separate sessions, spread over an anticipated time frame of 3 months.
Time frame: 3 months
Performance in music discrimination tests
Participants perform an adaptive music discrimination test in which their discrimination thresholds are measured.
Time frame: 3 months
This study is completed, as verified in Jan 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.